Resolution of Osseous Sarcoidosis with Methotrexate

Joint Authors

Kanner, Christopher
Libman, Bonita
Merchand, Morgan
Lemos, Diego

Source

Case Reports in Rheumatology

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-5, 5 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-11-11

Country of Publication

Egypt

No. of Pages

5

Main Subjects

Diseases

Abstract EN

Though a relatively uncommon manifestation of sarcoidosis, some clinicians are tasked with managing osseous involvement of disease, and the optimal treatment approach in this setting is not well established.

Previous studies have shown variable efficacy for osseous sarcoidosis utilizing multiple agents alone or in combination, often using imaging follow-up in conjunction with clinical assessment to evaluate response to treatment.

We present a case of widespread skeletal involvement of sarcoidosis without evidence of concurrent pulmonary disease demonstrating marked clinical improvement and near-complete resolution of imaging abnormalities on magnetic resonance imaging (MRI) following the use of methotrexate as the primary pharmacologic agent.

American Psychological Association (APA)

Kanner, Christopher& Libman, Bonita& Merchand, Morgan& Lemos, Diego. 2019. Resolution of Osseous Sarcoidosis with Methotrexate. Case Reports in Rheumatology،Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1144217

Modern Language Association (MLA)

Kanner, Christopher…[et al.]. Resolution of Osseous Sarcoidosis with Methotrexate. Case Reports in Rheumatology No. 2019 (2019), pp.1-5.
https://search.emarefa.net/detail/BIM-1144217

American Medical Association (AMA)

Kanner, Christopher& Libman, Bonita& Merchand, Morgan& Lemos, Diego. Resolution of Osseous Sarcoidosis with Methotrexate. Case Reports in Rheumatology. 2019. Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1144217

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1144217